The nickel(II) complex of guanidinium phenyl porphyrin, a specific G-quadruplex ligand, targets telomeres and leads to POT1 mislocalization in culture cells

[1]  S. Bhattacharya,et al.  Advances in the molecular design of potential anticancer agents via targeting of human telomeric DNA. , 2014, Chemical communications.

[2]  N. Zaffaroni,et al.  G-Quadruplex Structures in the Human Genome as Novel Therapeutic Targets , 2013, Molecules.

[3]  A. López-Guillermo,et al.  POT1 mutations cause telomere dysfunction in chronic lymphocytic leukemia , 2013, Nature Genetics.

[4]  J. Mergny,et al.  A FRET-based screening assay for nucleic acid ligands. , 2012, Methods.

[5]  A. Serero,et al.  Formation of pearl-necklace monomorphic G-quadruplexes in the human CEB25 minisatellite. , 2012, Journal of the American Chemical Society.

[6]  Jean-Louis Mergny,et al.  Interaction of human telomeric DNA with N-methyl mesoporphyrin IX , 2012, Nucleic acids research.

[7]  P. Dumy,et al.  Improvement of porphyrins for G-quadruplex DNA targeting. , 2011, Biochimie.

[8]  P. Labbé,et al.  Template-assembled synthetic G-quadruplex (TASQ): a useful system for investigating the interactions of ligands with constrained quadruplex topologies. , 2010, Chemistry.

[9]  J. Mergny,et al.  “One Ring to Bind Them All”—Part I: The Efficiency of the Macrocyclic Scaffold for G-Quadruplex DNA Recognition , 2010, Journal of nucleic acids.

[10]  J. Mergny,et al.  “One Ring to Bind Them All”—Part II: Identification of Promising G-Quadruplex Ligands by Screening of Cyclophane-Type Macrocycles , 2010, Journal of nucleic acids.

[11]  Stephen Neidle,et al.  Human telomeric G‐quadruplex: The current status of telomeric G‐quadruplexes as therapeutic targets in human cancer , 2010, The FEBS journal.

[12]  J. Karlseder,et al.  Telomeric armor: the layers of end protection , 2009, Journal of Cell Science.

[13]  A. Phan,et al.  Sequence variant (CTAGGG)n in the human telomere favors a G-quadruplex structure containing a G·C·G·C tetrad , 2009, Nucleic acids research.

[14]  S. Balasubramanian,et al.  G-quadruplex nucleic acids as therapeutic targets. , 2009, Current opinion in chemical biology.

[15]  A. Phan,et al.  A novel chair-type G-quadruplex formed by a Bombyx mori telomeric sequence , 2008, Nucleic acids research.

[16]  Kwok‐yin Wong,et al.  G‐Quadruplexes: Targets in Anticancer Drug Design , 2008, ChemMedChem.

[17]  Carlo Leonetti,et al.  Telomere damage induced by the G-quadruplex ligand RHPS4 has an antitumor effect. , 2007, The Journal of clinical investigation.

[18]  Stephen Neidle,et al.  Mechanism of acridine-based telomerase inhibition and telomere shortening. , 2007, Biochemical pharmacology.

[19]  Markus Kaiser,et al.  Fluorescence-based melting assays for studying quadruplex ligands. , 2007, Methods.

[20]  Hamid Morjani,et al.  Telomestatin-induced Telomere Uncapping Is Modulated by POT1 through G-overhang Extension in HT1080 Human Tumor Cells* , 2006, Journal of Biological Chemistry.

[21]  Sarah W. Burge,et al.  Quadruplex DNA: sequence, topology and structure , 2006, Nucleic acids research.

[22]  K. Shin‐ya,et al.  The G-quadruplex ligand telomestatin inhibits POT1 binding to telomeric sequences in vitro and induces GFP-POT1 dissociation from telomeres in human cells. , 2006, Cancer research.

[23]  T. Lange,et al.  Shelterin: the protein complex that shapes and safeguards human telomeres , 2005 .

[24]  A. Phan,et al.  Small-molecule interaction with a five-guanine-tract G-quadruplex structure from the human MYC promoter , 2005, Nature chemical biology.

[25]  J. Mergny,et al.  Apoptosis related to telomere instability and cell cycle alterations in human glioma cells treated by new highly selective G-quadruplex ligands , 2005, Oncogene.

[26]  Stephen Neidle,et al.  The G-quadruplex-interactive molecule BRACO-19 inhibits tumor growth, consistent with telomere targeting and interference with telomerase function. , 2005, Cancer research.

[27]  Roger A. Jones,et al.  Solution structure of the biologically relevant G-quadruplex element in the human c-MYC promoter. Implications for G-quadruplex stabilization. , 2005, Biochemistry.

[28]  T. Lange,et al.  POT1 as a terminal transducer of TRF1 telomere length control , 2003, Nature.

[29]  J. Boucher,et al.  First non-alpha-amino acid guanidines acting as efficient NO precursors upon oxidation by NO-synthase II or activated mouse macrophages. , 2002, Biochemistry.

[30]  J. Mergny,et al.  Cell senescence and telomere shortening induced by a new series of specific G-quadruplex DNA ligands , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[31]  E. Raymond,et al.  Effects of cationic porphyrins as G-quadruplex interactive agents in human tumor cells. , 1999, Cancer research.

[32]  R. Wheelhouse,et al.  Cationic Porphyrins as Telomerase Inhibitors: the Interaction of Tetra-(N-methyl-4-pyridyl)porphine with Quadruplex DNA , 1998 .

[33]  J. Shay,et al.  Normal human chromosomes have long G-rich telomeric overhangs at one end. , 1997, Genes & development.

[34]  J. Shay,et al.  Telomerase activity in human cancer. , 1996, Current opinion in oncology.

[35]  J. Shay,et al.  Telomerase activity in human germline and embryonic tissues and cells. , 1996, Developmental genetics.

[36]  T. C. Bruice,et al.  Synthesis and DNA-binding studies of new cationic guanidine and betaineamide tetraphenylporphyrins , 1991 .

[37]  David M. Prescott,et al.  Inhibition of telomerase by G-quartet DMA structures , 1991, Nature.

[38]  L. S. Cram,et al.  A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[39]  B. A. White,et al.  Electrochemical polymerization of amino-, pyrrole-, and hydroxy-substituted tetraphenylporphyrins , 1987 .

[40]  K. Hagino-Yamagishi,et al.  [Oncogene]. , 2019, Gan to kagaku ryoho. Cancer & chemotherapy.

[41]  R. Roskoski,et al.  Adenosine 3',5'-monophosphate-dependent protein kinase: interaction with guanidinium compounds. , 1980, Archives of biochemistry and biophysics.

[42]  Rspm μgm.  Methods , 1972 .